Renalytix Reported Earlier That Medicare Issued Final Local Coverage Determination For kidneyintelX.dkd Testing
Portfolio Pulse from Benzinga Newsdesk
Renalytix announced that Medicare has issued a final local coverage determination for its kidneyintelX.dkd testing.
June 14, 2024 | 2:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Renalytix has received final Medicare coverage for its kidneyintelX.dkd testing, which is a significant regulatory milestone. This approval could lead to increased adoption and revenue growth for the company.
The final Medicare coverage determination is a critical regulatory approval that can significantly boost the adoption of kidneyintelX.dkd testing. This is likely to positively impact Renalytix's revenue and market position.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100